Pharma-Bio Third-Quarter 2016 Update: $5.8 Billion Investment in Project Starts Reflects Good Health of the Industry
Attachment: pharmastart
SUGAR LAND--September 7, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--By the time third-quarter 2016 comes to a close, the Pharmaceutical-Biotech Industry is on target to have launched nearly $6 billion worth of North American capital and maintenance (MRO) projects. The third-quarter 2016 tally reflects a whopping 50% increase over the figures for the same period last year.
Within this article: Details of the Outremont Science and Education Pavilion project.
Additional companies: Alexion Pharmaceuticals (NASDAQ:ALXN)
